000908.SZ SHZ
Hunan Jingfeng Pharmaceutical Co.,Ltd.
1W: -1.8%
1M: -7.1%
3M: -4.2%
YTD: -10.2%
1Y: -0.2%
3Y: +133.1%
5Y: +18.1%
¥5.99 ($0.89)
+0.04 (+0.67%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$6M
-115.8% ▼
Capital Expenditures
$1M
+86.7% ▲
5Y CAGR: -58.6%
Free Cash Flow
-$7M
-128.1% ▼
Dividends Paid
$13M
+43.2% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$48M
+128.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$1.0B | -$202M | -$101M | -$207M | $159M |
| Depreciation & Amort. | $81M | $107M | $55M | $44M | $29M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $159M | $322M | $73M | $97M | $13M |
| Other Non-Cash Items | $536M | -$104M | $96M | $100M | -$207M |
| Operating Cash Flow | -$272M | $124M | $123M | $35M | -$6M |
| — Investing Activities — | |||||
| Capital Expenditures | -$96M | -$38M | -$14M | -$10M | -$1M |
| Acquisitions (Net) | $434M | $253M | $64M | $0 | $0 |
| Investment Purchases | -$250M | $1 | -$0 | $0 | $0 |
| Investment Sales | $353M | $45M | $53M | $5M | $0 |
| Other Investing | $2M | $12M | $118M | -$4M | $66M |
| Investing Cash Flow | $443M | $273M | $222M | -$9M | $64M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$533M | -$281M | -$296M | -$16M | -$5M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$89M | -$91M | -$40M | -$24M | -$13M |
| Other Financing | $207M | -$14M | -$745K | -$154M | $8M |
| Financing Cash Flow | -$415M | -$387M | -$336M | -$193M | -$11M |
| Net Change in Cash | -$246M | $9M | $9M | -$167M | $48M |
| Cash End of Period | $160M | $169M | $178M | $11M | $59M |
| Free Cash Flow | -$368M | $86M | $110M | $25M | -$7M |